Category: Psychedelic Bulletin - Page 18 - Psychedelic Alpha

Read more about the article Psychedelic Bulletin: Psychedelics Companies Embrace Tech; MindMed to Study LSD Microdosing; UFC Eyes Psychedelics

Psychedelic Bulletin: Psychedelics Companies Embrace Tech; MindMed to Study LSD Microdosing; UFC Eyes Psychedelics

Post published:January 15, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: MindMed Raises $92.1m; Mount Sinai Establishes Psychedelics Centre; More Legal Exemptions for Psilocybin in Canada

Psychedelic Bulletin: MindMed Raises $92.1m; Mount Sinai Establishes Psychedelics Centre; More Legal Exemptions for Psilocybin in Canada

Post published:January 8, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: First Psychedelic ETF Set to Launch; Beckley Psytech Raises £14m; Reviewing the Psychedelic Renaissance in 2020

Psychedelic Bulletin: First Psychedelic ETF Set to Launch; Beckley Psytech Raises £14m; Reviewing the Psychedelic Renaissance in 2020

Post published:January 2, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics

Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics

Post published:December 18, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial

Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial

Post published:December 11, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD

Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD

Post published:December 4, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: ATAI Raises $125m, MindMed CAD $25m; BBC Programme to Follow Psychedelics Trial

Psychedelic Bulletin: ATAI Raises $125m, MindMed CAD $25m; BBC Programme to Follow Psychedelics Trial

Post published:November 27, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial

Psychedelic Bulletin: Non-Palliative Canadian Receives Psilocybin Therapy; Germany Backs Psilocybin Study; MindMed Moves Forward with LSD for ADHD Trial

Post published:November 20, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Post published:November 13, 2020
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Psychedelics Decriminalised in OR and DC; Cybin and Entheon to Go Public

Psychedelic Bulletin: Psychedelics Decriminalised in OR and DC; Cybin and Entheon to Go Public

Post published:November 6, 2020
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.